Vasculitis & polymyalgia rheumatica

Clinical features and independent predictors of Behçet's disease associated with myelodysplastic syndrome

Clin Exp RheumatolPublished Retrospective study

Authors' conclusion

Our findings suggest that cytogenetic abnormalities, especially trisomy 8, may play a role in the association of GI involvement, BD, and MDS. GI involvement, low haemoglobin, and high ESR level were independent predictors for MDS development in BD patients.

Study context

Population
Chinese patients with Behçet's disease (BD) associated with myelodysplastic syndrome (MDS), First Affiliated Hospital of Zhengzhou University10 females, 5 males (BD-MDS)
Participants
15 / 60 / 60
Exposure
BD-MDS vs general BD without MDS; vs primary MDS without BD
  • BD-MDSn = 15
  • BD without MDSn = 60reference
  • Primary MDSn = 60reference
Outcome
Clinical features of BD-MDS
Methodological detailssingle-centre, comparison with BD without MDS and with primary MDS without BD, logistic regression
  • Single-centre
  • Comparison with BD without MDS and with primary MDS without BD
  • Logistic regression

Main finding

As reported in the abstract

Abnormal karyotype

13

86.7%

Trisomy 8

11

Gastrointestinal (GI) involvement

10

66.7%

Observational data: associations, not effects.

Further findings

BD-MDS vs BD without MDS

BD-MDS significantly older; fever and GI involvement more common; lower leukocyte count, haemoglobin and platelet count (p<0.05)
GI involvement, low haemoglobin and high erythrocyte sedimentation rate (ESR) independently associated with MDS development in BD (logistic regression)

IBD-MDS vs IBD without MDS

IBD-MDS older, more fever, lower leukocyte count, haemoglobin and platelet count, higher ESR and CRP (p<0.05)

BD-MDS vs primary MDS

More abnormal karyotypes and more trisomy 8 in BD-MDS (p<0.05)
Distribution of 2016 WHO MDS subtypes and IPSS-R categories similar

Original publication

Clinical features and independent predictors of Behçet's disease associated with myelodysplastic syndrome. Clin Exp Rheumatol. Published 15 August 2022. doi:10.55563/clinexprheumatol/04us5e

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.